New Horizon Health Ltd

HKSE:06606 (China)   Ordinary Shares
HK$ 14.14 (0%) Jun 7
59.16
P/B:
1.98
Market Cap:
HK$ 6.34B ($ 812.23M)
Enterprise V:
HK$ 5.00B ($ 639.50M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for New Horizon Health Ltd ( ) from 2021 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. New Horizon Health stock (HKSE:06606) PE ratio as of Jun 08 2024 is 59.16. More Details

New Horizon Health Ltd (HKSE:06606) PE Ratio (TTM) Chart

To

New Horizon Health Ltd (HKSE:06606) PE Ratio (TTM) Historical Data

Total 815
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10
New Horizon Health PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-08 59.2 2024-04-03 59.2
2024-06-07 59.2 2024-04-02 59.2
2024-06-06 59.2 2024-03-28 59.2
2024-06-05 59.2 2024-03-27 59.2
2024-06-04 59.2 2024-03-26 73.7
2024-06-03 59.2 2024-03-25 77.8
2024-05-31 59.2 2024-03-22 76.9
2024-05-30 59.2 2024-03-21 76.9
2024-05-29 59.2 2024-03-20 76.5
2024-05-28 59.2 2024-03-19 78.5
2024-05-27 59.2 2024-03-18 81.2
2024-05-24 59.2 2024-03-15 81.9
2024-05-23 59.2 2024-03-14 84.9
2024-05-22 59.2 2024-03-13 88.9
2024-05-21 59.2 2024-03-12 89.3
2024-05-20 59.2 2024-03-11 87.2
2024-05-17 59.2 2024-03-08 80.2
2024-05-16 59.2 2024-03-07 81.6
2024-05-14 59.2 2024-03-06 83.7
2024-05-13 59.2 2024-03-05 83.1
2024-05-10 59.2 2024-03-04 87.5
2024-05-09 59.2 2024-03-01 84.3
2024-05-08 59.2 2024-02-29 85.4
2024-05-07 59.2 2024-02-28 85.8
2024-05-06 59.2 2024-02-27 87.7
2024-05-03 59.2 2024-02-26 83.9
2024-05-02 59.2 2024-02-23 84.3
2024-04-30 59.2 2024-02-22 81.6
2024-04-29 59.2 2024-02-21 80.3
2024-04-26 59.2 2024-02-20 80.3
2024-04-25 59.2 2024-02-19 79.8
2024-04-24 59.2 2024-02-16 79.9
2024-04-23 59.2 2024-02-15 74.9
2024-04-22 59.2 2024-02-14 74.1
2024-04-19 59.2 2024-02-09 74.1
2024-04-18 59.2 2024-02-08 76.7
2024-04-17 59.2 2024-02-07 74.7
2024-04-16 59.2 2024-02-06 73.4
2024-04-15 59.2 2024-02-05 66.5
2024-04-12 59.2 2024-02-02 65.3
2024-04-11 59.2 2024-02-01 70.9
2024-04-10 59.2 2024-01-31 71.0
2024-04-09 59.2 2024-01-30 73.6
2024-04-08 59.2 2024-01-29 76.9
2024-04-05 59.2 2024-01-26 79.2

New Horizon Health Ltd (HKSE:06606) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.